APPY Related Analyst Ratings
-
Canaccord Genuity Upgrades Venaxis (APPY) to Buy, Shares Ramp
-
Canaccord Genuity Reiterates a 'Hold' on AspenBio Pharma (APPY); Submitted pre-IDE; Expect Frequent Updates
-
Canaccord Genuity Maintains a 'Hold' on AspenBio Pharma (APPY); Q2 Preview: Trials For AppyScore Start Soon
-
Canaccord Genuity maintains a 'Hold' on AspenBio Pharma (APPY); Several Moving Parts
-
Canaccord Genuity Maintains a 'Hold' on AspenBio Pharma (APPY); Not Losing Sight of Big Picture
-
Canaccord Genuity Maintains a 'Hold' on AspenBio Pharma (AAPY); Multi-marker Panel Likely Key to Approval & Uptake
-
Canaccord Genuity Reiterates a 'Hold' on AspenBio Pharma (APPY); Clinical Timelines Updated
-
Canaccord Genuity Maintains a 'Hold' on AspenBio Pharma (APPY); Update with Management
-
Canaccord Genuity Initiates Coverage on Life Sciences – Biomedical Devices and Services Stocks
-
Canaccord Genuity Starts AspenBio Pharma (APPY) at Hold, Price Target $0.50
-
ThinkEquity Downgrades AspenBio Pharma (APPY) to Hold
-
ThinkEquity Initiates Coverage on AspenBio (APPY) with a Buy
-
Lazard Capital Starts AspenBio Pharma (APPY) at Buy
-
Oppenheimer Downgrades AspenBio Pharma (APPY) to Perform
-
Canaccord Adams Starts AspenBio Pharma (APPY) at Buy
-
Oppenheimer Starts AspenBio Pharma (APPY) at Buy
Back to APPY Stock Lookup
